Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Nobumitsu Tamaki"'
Publikováno v:
Journal of Clinical Oncology. 40:e13026-e13026
e13026 Background: With the incorporation of anti-HER2 agents in the treatment of HER2 positive primary breast cancer, stage 4 disease of this subtype has become potentially curable. However, the duration of clinical CR that is needed be certain that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b62712de2298c8824668d0bbcc81512
https://doi.org/10.1200/jco.2022.40.16_suppl.e13026
https://doi.org/10.1200/jco.2022.40.16_suppl.e13026
Autor:
Yasuhiro Miki, Ayako Kanai, Nobumitsu Tamaki, Naoko Takigami, Yoshihiko Kamada, Hironobu Sasano, Shigeharu Terukina, Kentaro Tamaki, Erina Iwabuchi, Seiko Tsuchiya, Shimpei Kuniyoshi, Minoru Miyashita, Takanori Ishida, Kano Uehara
Publikováno v:
Breast cancer research and treatment. 189(1)
Purpose: Diabetes Mellitus (DM) has been one of the well known risk factors of breast cancer (BC) development and also associated with adverse clinical outcomes of BC patients. Glucagon-like peptide-1 (GLP-1) receptor agonists have been used as antid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554e97f7f9dc42dab1c9ebb698f629c9
https://pubmed.ncbi.nlm.nih.gov/34606001
https://pubmed.ncbi.nlm.nih.gov/34606001
Autor:
Minoru Miyashita, M Takaesu, Takanori Ishida, Yoshihiko Kamada, K Yamashiro, Hironobu Sasano, Kanou Uehara, Keely May McNamara, Shigeharu Terukina, Kentaro Tamaki, Nobumitsu Tamaki, M Arakaki, S Nagamine, Naoko Takigami
Publikováno v:
Cancer Research. 78:P6-11
Aromatase inhibitors (AIs) have been used in the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer as a consequence of the significant benefit in DFS and OS when compared with tamoxifen. However the patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aea8e078f817d75744088934577eeab
https://doi.org/10.1158/1538-7445.sabcs17-p6-11-01
https://doi.org/10.1158/1538-7445.sabcs17-p6-11-01
Autor:
Kano Uehara, Hironobu Sasano, Shigeharu Terukina, Seiko Tsuchiya, Yoshihiko Kamada, Yasuhiro Miki, Kentaro Tamaki, Shimpei Kuniyoshi, Minoru Miyashita, Erina Iwabuchi, Ayako Kanai, Nobumitsu Tamaki, Naoko Takigami, Takanori Ishida
Publikováno v:
Breast Cancer Research and Treatment. 191:221-221
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffdd928ef064c83e3833ab6955de7823
https://doi.org/10.1007/s10549-021-06380-8
https://doi.org/10.1007/s10549-021-06380-8
Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
Autor:
Mikiko Unesoko, Naoki Yoshimi, Kano Uehara, Kentaro Tamaki, Yoshihiko Kamada, Norie Abe, Reika Takamatsu, Nobumitsu Tamaki, Hirofumi Matsumoto, Norihiro Nakada, Tokiwa Motonari, Hisamitsu Zaha, Naoko Takigami
Publikováno v:
Virchows Archiv : an international journal of pathology. 476(5)
As visual quantification of the density of tumor-infiltrating lymphocytes (TILs) lacks in precision, digital image analysis (DIA) approach has been applied in order to improve. In several studies, TIL density has been examined on hematoxylin and eosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5851f686e1d8ddf80d5a5255a070086d
https://pubmed.ncbi.nlm.nih.gov/31873876
https://pubmed.ncbi.nlm.nih.gov/31873876
Autor:
M Arakaki, Shigeharu Terukina, Yoshihiko Kamada, K Yamashiro, Kentaro Tamaki, Kanou Uehara, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, A Komatsu-Fukuyama, Hironobu Sasano, Nobumitsu Tamaki
Publikováno v:
Cancer Research. 76:P1-10
PURPOSE: The aromatherapy has been performed as palliative care of the breast cancer patients but no studies have been reported regarding whether the therapy improved QOL of the patients during perioperative periods or not. Therefore, in this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce77a72a26a4c7a56c1cc5b8388cd02f
https://doi.org/10.1158/1538-7445.sabcs15-p1-10-29
https://doi.org/10.1158/1538-7445.sabcs15-p1-10-29
Autor:
Naoko Takigami, Kanou Uehara, Seiko Tsuchiya, Nobumitsu Tamaki, Yoshihiko Kamada, Kentaro Tamaki
Publikováno v:
Journal of Clinical Oncology. 38:e12535-e12535
e12535 Background: Oncotype Dx is becoming the standard assay for chemotherapy decision making for estrogen receptor positive / HER2 negative early breast cancer. Issues concerning the choice of therapy for the intermediate risk patients are currentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33ea06ac408096b0babd1ab885d45393
https://doi.org/10.1200/jco.2020.38.15_suppl.e12535
https://doi.org/10.1200/jco.2020.38.15_suppl.e12535
Autor:
Hirofumi Matsumoto, Naoki Yoshimi, Yoshihiko Kamada, Tokiwa Motonari, Norie Abe, Hisamitsu Zaha, Kanou Uehara, Norihiro Nakada, Naoko Takigami, Kentaro Tamaki, Nobumitsu Tamaki, Reika Takamatsu
Publikováno v:
Cancer Research. 80:PD5-04
Purpose: To evaluate tumor-infiltrating lymphocytes (TILs) quantitatively in breast cancer and to verify the utility of machine learning image analysis in TIL assessment. Methods: Stromal TILs in 105 Human epidermal growth factor receptor 2 (HER2)-po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::424da58f087732f62884c72d4a87ee82
https://doi.org/10.1158/1538-7445.sabcs19-pd5-04
https://doi.org/10.1158/1538-7445.sabcs19-pd5-04
Autor:
Keely May McNamara, Minoru Miyashita, Nobumitsu Tamaki, Takanori Ishida, Kentaro Tamaki, Kano Uehara, Yoshihiko Kamada, Hironobu Sasano, Seiko Tsuchiya, Shigeharu Terukina, Naoko Takigami
Publikováno v:
Cancer Research. 80:P6-01
Introduction: Mammographic density (MD) has been reported to be associated with increased risk of breast cancer development. In addition, the association of MD with breast cancer subtypes has been proposed in Caucasian breast cancer patients but this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbf15fe94d05d94073c9e6e32c3ebd09
https://doi.org/10.1158/1538-7445.sabcs19-p6-01-01
https://doi.org/10.1158/1538-7445.sabcs19-p6-01-01
Autor:
Shimpei Kuniyoshi, Seiko Tsuchiya, Ayako Kanai, Takanori Ishida, Kentaro Tamaki, Kano Uehara, Hironobu Sasano, Yasuhiko Miki, Yoshihiko Kamada, Keely May McNamara, Naoko Takigami, Minoru Miyashita, Shigeharu Terukina, Nobumitsu Tamaki
Publikováno v:
Cancer Research. 80:P3-02
Introduction: Diabetes mellitus (DM) has been generally considered one of the risk factors of breast cancer (BC) development. Glucagon-like-peptide-1 (GLP-1) has been reported to be associated with increased risks of cancer development in some human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4e5cc2a0537dcd6797fc557c730f196
https://doi.org/10.1158/1538-7445.sabcs19-p3-02-10
https://doi.org/10.1158/1538-7445.sabcs19-p3-02-10